The article "Global Perspectives on the Hepatitis B Vaccination: Challenges, Achievements, and the Road to Elimination by 2030" by Said A. Al-Busafi and Ahmed Alwassief provides a comprehensive review of the global efforts to combat hepatitis B (HBV) and achieve the World Health Organization's (WHO) ambitious goal of eliminating HBV by 2030. The authors highlight the significant health burden of HBV, with over 1.5 million new infections and 820,000 deaths annually, and emphasize the critical role of vaccination in preventing chronic hepatitis B and its complications. Key points include: - **Global Impact**: HBV remains a significant public health threat, causing acute and chronic liver diseases and contributing to high mortality rates. - **Vaccination Coverage**: Despite progress, global birth dose coverage is only 46%, and there are disparities in access to vaccination, diagnostics, and treatments, particularly in resource-limited settings. - **WHO's Goals**: The WHO aims to achieve 90% vaccination coverage and reduce new infections by 90% by 2030, with a 65% reduction in mortality. - **Challenges and Strategies**: The article discusses the challenges in achieving these goals, such as vaccine escape mutants, genotypic variability, and vaccine non-responders, and explores strategies to enhance vaccine efficacy and coverage. - **Cost-Effectiveness**: Universal vaccination is shown to be cost-effective, especially in high-risk populations, and can lead to substantial health and economic benefits. - **Recent Advances**: Innovations like machine learning and alternative vaccination routes are being explored to improve vaccine immunogenicity and coverage. The review underscores the importance of continued global efforts, including robust vaccination programs, enhanced diagnostics, and improved healthcare infrastructure, to achieve the WHO's 2030 elimination targets.The article "Global Perspectives on the Hepatitis B Vaccination: Challenges, Achievements, and the Road to Elimination by 2030" by Said A. Al-Busafi and Ahmed Alwassief provides a comprehensive review of the global efforts to combat hepatitis B (HBV) and achieve the World Health Organization's (WHO) ambitious goal of eliminating HBV by 2030. The authors highlight the significant health burden of HBV, with over 1.5 million new infections and 820,000 deaths annually, and emphasize the critical role of vaccination in preventing chronic hepatitis B and its complications. Key points include: - **Global Impact**: HBV remains a significant public health threat, causing acute and chronic liver diseases and contributing to high mortality rates. - **Vaccination Coverage**: Despite progress, global birth dose coverage is only 46%, and there are disparities in access to vaccination, diagnostics, and treatments, particularly in resource-limited settings. - **WHO's Goals**: The WHO aims to achieve 90% vaccination coverage and reduce new infections by 90% by 2030, with a 65% reduction in mortality. - **Challenges and Strategies**: The article discusses the challenges in achieving these goals, such as vaccine escape mutants, genotypic variability, and vaccine non-responders, and explores strategies to enhance vaccine efficacy and coverage. - **Cost-Effectiveness**: Universal vaccination is shown to be cost-effective, especially in high-risk populations, and can lead to substantial health and economic benefits. - **Recent Advances**: Innovations like machine learning and alternative vaccination routes are being explored to improve vaccine immunogenicity and coverage. The review underscores the importance of continued global efforts, including robust vaccination programs, enhanced diagnostics, and improved healthcare infrastructure, to achieve the WHO's 2030 elimination targets.